Markets:

Overview

News

Currencies

International

Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

72.25 +4.91 (+7.29%)

Delayed Quote Updated: 9:35 AM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

December 03, 2024

Via Benzinga

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

1 Top Growth Stock Down 56% to Buy After Its Recent Pullback ↗

November 26, 2024

This growth stock has been on my watchlist for a while and might soon be included in my portfolio.

Via The Motley Fool

2 Hypergrowth Stocks That Are Screaming Buys in November ↗

November 23, 2024

Via The Motley Fool

Looking Into TransMedics Gr's Recent Short Interest ↗

November 21, 2024

Via Benzinga

Navigating 11 Analyst Ratings For TransMedics Gr ↗

November 18, 2024

Via Benzinga

This Is What Whales Are Betting On TransMedics Gr ↗

October 30, 2024

Via Benzinga

Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock ↗

October 29, 2024

Via Benzinga

This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

November 22, 2024

Via Benzinga

Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior' ↗

November 20, 2024

Amphenol (APH) is a terrific stock, reporting better-than-expected earnings, while Cramer prefers CTRA over DVN and doesn't see potential in TMDX.

Via Benzinga

Is TransMedics Group Stock a Buy? ↗

November 15, 2024

This organ transplant specialist is down, but still has plenty of signs of life.

Via The Motley Fool

Down 52%, Is TransMedics Stock a Buy on the Dip? ↗

November 09, 2024

Sales growth is tapering off for this provider of delivery services for transplant organs.

Via The Motley Fool

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)

November 07, 2024

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Why TransMedics Stock Plunged in October ↗

November 07, 2024

The organ transplant specialist posted disappointing results in its third-quarter report.

Via The Motley Fool

1 Top Growth Stock Down 50% to Buy After Its Recent Pullback ↗

November 04, 2024

TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.

Via The Motley Fool

Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review ↗

November 01, 2024

The major indexes declined, but haven't fallen apart.

Via Investor's Business Daily

3 Stocks Well Below 52-Week Highs With Strong Growth Projections

November 01, 2024

These three stocks are trading deeply below their 52-week highs, and analyst project them to see big increases in earnings and revenue over coming years.

Via MarketBeat

Topics Immigration

TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

October 30, 2024

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results ↗

October 29, 2024

Via Benzinga

Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries ↗

October 29, 2024

TransMedics Group shares fall as Q3 EPS misses estimates; revenue rises 64% but falls short of consensus. Analysts cut price targets, citing weaker transplant volumes.

Via Benzinga

Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views ↗

October 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 29, 2024

Via Benzinga

These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results ↗

October 29, 2024

Via Benzinga

TransMedics Stock Crashes After Earnings Disappointment. Time to Load Up the Boat? ↗

October 29, 2024

Is this the buy-the-dip opportunity investors have been waiting for?

Via The Motley Fool

TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

October 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 29, 2024

Via Benzinga

Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 29, 2024

Via Benzinga

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

October 29, 2024

Via Benzinga

INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm

October 28, 2024

From DiCello Levitt LLP

Via GlobeNewswire

TransMedics, F5 Lead Big After-Hours Earnings Winners, Losers ↗

October 28, 2024

With earnings season in full swing, big movers abound.

Via Investor's Business Daily

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.